Barker RA - Search Results

1

Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease.

Goris A, Williams-Gray CH, Clark GR, Foltynie T, Lewis SJ, Brown J, Ban M, Spillantini MG, Compston A, Burn DJ, Chinnery PF, Barker RA, Sawcer SJ. Goris A, et al. Among authors: barker ra. Ann Neurol. 2007 Aug;62(2):145-53. doi: 10.1002/ana.21192. Ann Neurol. 2007. PMID: 17683088

2

The heterogeneity of idiopathic Parkinson's disease.

Foltynie T, Brayne C, Barker RA. Foltynie T, et al. Among authors: barker ra. J Neurol. 2002 Feb;249(2):138-45. doi: 10.1007/pl00007856. J Neurol. 2002. PMID: 11985378 Review.

3

Using executive heterogeneity to explore the nature of working memory deficits in Parkinson's disease.

Lewis SJ, Cools R, Robbins TW, Dove A, Barker RA, Owen AM. Lewis SJ, et al. Among authors: barker ra. Neuropsychologia. 2003;41(6):645-54. doi: 10.1016/s0028-3932(02)00257-9. Neuropsychologia. 2003. PMID: 12591022

4

Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry.

Lewis SJ, Dove A, Robbins TW, Barker RA, Owen AM. Lewis SJ, et al. Among authors: barker ra. J Neurosci. 2003 Jul 16;23(15):6351-6. doi: 10.1523/JNEUROSCI.23-15-06351.2003. J Neurosci. 2003. PMID: 12867520 Free PMC article. Clinical Trial.

5

The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study.

Foltynie T, Brayne CE, Robbins TW, Barker RA. Foltynie T, et al. Among authors: barker ra. Brain. 2004 Mar;127(Pt 3):550-60. doi: 10.1093/brain/awh067. Epub 2003 Dec 22. Brain. 2004. PMID: 14691062

6

The potential of GDNF as a treatment for Parkinson's disease.

Hurelbrink CB, Barker RA. Hurelbrink CB, et al. Among authors: barker ra. Exp Neurol. 2004 Jan;185(1):1-6. doi: 10.1016/j.expneurol.2003.09.018. Exp Neurol. 2004. PMID: 14697313 No abstract available.

7

Striatal contributions to working memory: a functional magnetic resonance imaging study in humans.

Lewis SJ, Dove A, Robbins TW, Barker RA, Owen AM. Lewis SJ, et al. Among authors: barker ra. Eur J Neurosci. 2004 Feb;19(3):755-60. doi: 10.1111/j.1460-9568.2004.03108.x. Eur J Neurosci. 2004. PMID: 14984425

8

Modern therapeutic approaches in Parkinson's disease.

Lewis SJ, Caldwell MA, Barker RA. Lewis SJ, et al. Among authors: barker ra. Expert Rev Mol Med. 2003 Mar 28;5(10):1-20. doi: 10.1017/S1462399403006008. Expert Rev Mol Med. 2003. PMID: 14987395 Review.

9

The future challenges in Parkinson's disease.

Barker RA, Foltynie T. Barker RA, et al. J Neurol. 2004 Mar;251(3):361-5. doi: 10.1007/s00415-004-0320-8. J Neurol. 2004. PMID: 15015024 Review. No abstract available.

10

Planning ability in Parkinson's disease is influenced by the COMT val158met polymorphism.

Foltynie T, Goldberg TE, Lewis SG, Blackwell AD, Kolachana BS, Weinberger DR, Robbins TW, Barker RA. Foltynie T, et al. Among authors: barker ra. Mov Disord. 2004 Aug;19(8):885-91. doi: 10.1002/mds.20118. Mov Disord. 2004. PMID: 15300652

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

645 results

Search Page

Filters